More About Us!

>> We recently updated our brochure about Highland Ophthalmology Vision Care Facility in New Windsor. Click here to view and print a copy!


ARTICLES

>> Article Written by Dr. Mary Davidian "Amniotic Membrane For Ocular Inflammation" Ophthalmology Management, June 1, 2013


NEWS


>>
Highland Ophthalmology Associates Offering New FDA-Approved Avedro Corneal Collagen Cross-Linking Procedure to Keratoconus Patients

>>
Highland Ophthalmology Establishes a Dry Eye Center of Excellence in the Hudson Valley of New York

>> Medical Eye Specialist Dr. Julia Mathews Joins New Windsor, New York Practice Highland Ophthalmology

>>
Highland Ophthalmology Introduces LipiFlow to Address Dry Eye Syndrome Caused by MGD

>>
Medical Eye Specialist Dr. Michael Stagner Joins New Windsor, New York Practice Highland Ophthalmology

>> Dr. Mary Davidian to Appear on American Health Front Program on NBC

>> Need for Eye Surgery Lessened by New Corneal Wound and Healing Treament

>> Highland Ophthalmology Opens New State-of-the-Art Vision Center

>> Highland Ophthalmology Celebrates Grand Opening of New Vision Center in New Windsor

>> Newburgh Ophthalmologists Offer Free Glaucoma Screenings Jan. 24

>> High-Tech Eye Care Right Here at Home

>> Eye Doctors Urge Exams During Glaucoma Awareness Month

>> Glaucoma Specialist Joins New Windsor, NY Ophthalmology Practice

>> New Windsor, NY Eye Surgeon Offers Alcon’s AcrySof® ReSTOR® Intraocular Lens for Cataract Correction

>> Alcon Launches AcrySof® ReSTOR® Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

>> CMS Ruling Provides Medicare Patients Access to Alcon’s AcrySof® ReSTOR® IOL

 


HOA Procedures

What is Keratoconus?

Keratoconus, often referred to as 'KC', is an eye condition in which the cornea weakens and thins over time, causing the development of a cone-like bulge and optical irregularity of the cornea. A rare condition, keratoconus typically first appears in individuals who are in their late teens or early twenties. Can result in significant visual loss and may lead to corneal transplant in severe cases.

In April 2016, the FDA approved Photrexa® Viscous (riboflavin 5'-phosphate sodium in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5'-phosphate sodium ophthalmic solution) and the Avedro KXL® System for corneal cross-linking, a minimally invasive outpatient procedure that combines the use of Vitamin B12 eye drops and ultra-violet (UV) light.

They are the first and only therapeutic products for corneal cross-linking which have been FDA approved to treat progressive keratoconus, and we offer them to patients in our practice. The approval of Photrexa Viscous, Photrexa and the Avedro KXL® System offers an effective treatment for patients who, until recently, had no therapeutic options to limit the progression of this sight-threatening disease.

What is Corneal Cross-Linking?

imageCorneal cross-linking is a minimally invasive outpatient procedure that combines the use of Photrexa® Viscous (riboflavin 5'-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5'-phosphate ophthalmic solution) and the Avedro KXL® System for the treatment of progressive keratoconus.

The safety and effectiveness of corneal cross-linking has not been established in pregnant women, women who are breastfeeding, patients who are less than 14 years of age and patients 65 years of age or older.

What are the side effects of corneal cross-linking?
- The most common ocular adverse reactions in any corneal cross-linked eye were haze (corneal opacity), inflammation (punctate keratitis), fine white lines (corneal striae), disruption of surface cells (corneal epithelium defect), eye pain, reduced sharpness of vision (visual acuity) and blurred vision.

What warnings should I know about corneal cross-linking?
- Ulcerative keratitis, a potentially serious eye infection, can occur.
- Your doctor should monitor you for resolution of epithelial defects if they occur.

Corneal Cross-Linking with Photrexa Viscous, Photrexa and the Avedro KXL® System

What can I expect during the procedure?
- Photrexa Viscous eye drops will be applied to the cornea for at least 30 min; Depending on the thickness of your cornea, Photrexa drops may also be required.
- The cornea is then exposed to UV light for 30 minutes while additional Photrexa Viscous drops are applied.
- After numbing drops are applied, the epithelium (the thin layer on the surface of the cornea) is gently removed.

What can I expect after the procedure?
- You should not rub your eyes for the first five days after the procedure.
- You may notice a sensitivity to light and have a foreign body sensation. You may also experience discomfort in the treated eye and sunglasses may help with light sensitivity.
- If you experience severe pain in the eye or any sudden decrease in vision, you should contact your physician immediately.
- If your bandage contact lens from the day of treatment falls out or becomes dislodged, you should not replace it and contact your physician immediately.

image

Our office is within an easy commute from the following areas in the Hudson Valley and Orange County and Dutchess County: New Windsor, Cornwall, Fishkill, Middletown, Florida, Warwick, Monroe, Harriman, Fort Montgomery, Highland Falls, Marlboro, Walden, Wallkill, Pine Bush, Vails Gate, Goshen, Salisbury Mills, Washingtonville, Campbell Hall, Montgomery, West Point, Modena, New Paltz, Highland, Beacon, Castle Point, Wappingers Falls, Poughkeepsie, NY.

With this, Highland Ophthalmology has become New Windsor's leading specialty eye care center. Call (845) 562-0138 today for your first consultation.

 




Highland Ophthalmology Associates on LinkedIn

     | 

 


To expedite your visit to Highland Ophthalmology please download and complete a New Patient Information Form prior to your first visit and present it to the receptionist when checking in:

Contact Us

Call us at (845) 562-0138 or fill out and submit this form to learn more about Highland Ophthalmology.

Please Note: Do not use this form for emergency purposes.

Name:*
Email:*
Phone:*
Comments:
* Required Fields

I agree to the Terms of Use
and Privacy Policy.


By checking the box, you are indicating that you have read, understand and consent to Highland Ophthalmology Associates Terms of Use and Privacy Policy.

 



AcrySof® IQ Toric IOLs

 


AcrySof® IQ ReSTOR® IOLs

 



PROKERA®

 


 


 

 

TearLab® Osmolarity System

 



Copyright © 2017
Highland Ophthalmology Associates, LLC.
All rights reserved.

140 Executive Drive
New Windsor, NY 12553

Telephone (845) 562-0138
Fax (845) 562-0147

To see a map of our location and get directions, click here.

   
About HOA Procedures

Dr. Mary Davidian
Dr. Thien Huynh
Dr. Julia Mathew
Dr. Michael Stagner
Dr. Sharon Bean Powell

Cataract Treatment
Corneal Transplants
Glaucoma Treatment
Dry Eye Treatment